Angelo Gordon & Co’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Angelo Gordon & Co’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300,000	Closed	-$3.07M	–	118
2023 Q1	$3.07M	Hold	300,000	–	–	0.77%	22
2022 Q4	$3.02M	Hold	300,000	–	–	0.55%	26
2022 Q3	$2.95M	Hold	300,000	–	–	0.53%	33
2022 Q2	$2.92M	Hold	300,000	–	–	0.32%	36
2022 Q1	$2.92M	Hold	300,000	–	–	0.33%	39
2021 Q4	$2.9M	Hold	300,000	–	–	0.27%	46
2021 Q3	$2.95M	Buy	+300,000	New	+$2.93M	0.17%	56

Angelo Gordon & Co's ORIA Position: Q2 2023 in Review

Angelo Gordon & Co sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 300,000 shares — an estimated $3.07M sold.

Angelo Gordon & Co first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $3.07M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Angelo Gordon & Co reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Angelo Gordon & Co sold 300,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $3.07M.
Angelo Gordon & Co first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Angelo Gordon & Co's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $3.07M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Angelo Gordon & Co's 13F filing for Q2 2023, filed 11 Aug 2023.